APA
Quayle S. N., Girgis N., Thapa D. R., Merazga Z., Kemp M. M., Histed A., Zhao F., Moreta M., Ruthardt P., Hulot S., Nelson A., Kraemer L. D., Beal D. R., Witt L., Ryabin J., Soriano J., Haydock M., Spaulding E., Ross J. F., Kiener P. A., Almo S., Chaparro R., Seidel R., Suri A., Cemerski S., Pienta K. J. & Simcox M. E. (20210127). CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Chicago
Quayle Steven N, Girgis Natasha, Thapa Dharma R, Merazga Zohra, Kemp Melissa M, Histed Alex, Zhao Fan, Moreta Miguel, Ruthardt Paige, Hulot Sandrine, Nelson Alyssa, Kraemer Lauren D, Beal Dominic R, Witt Luke, Ryabin Jessica, Soriano Jonathan, Haydock Mark, Spaulding Emily, Ross John F, Kiener Peter A, Almo Steven, Chaparro Rodolfo, Seidel Ronald, Suri Anish, Cemerski Saso, Pienta Kenneth J and Simcox Mary Ellen. 20210127. CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Harvard
Quayle S. N., Girgis N., Thapa D. R., Merazga Z., Kemp M. M., Histed A., Zhao F., Moreta M., Ruthardt P., Hulot S., Nelson A., Kraemer L. D., Beal D. R., Witt L., Ryabin J., Soriano J., Haydock M., Spaulding E., Ross J. F., Kiener P. A., Almo S., Chaparro R., Seidel R., Suri A., Cemerski S., Pienta K. J. and Simcox M. E. (20210127). CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. : Clinical cancer research : an official journal of the American Association for Cancer Research.
MLA
Quayle Steven N, Girgis Natasha, Thapa Dharma R, Merazga Zohra, Kemp Melissa M, Histed Alex, Zhao Fan, Moreta Miguel, Ruthardt Paige, Hulot Sandrine, Nelson Alyssa, Kraemer Lauren D, Beal Dominic R, Witt Luke, Ryabin Jessica, Soriano Jonathan, Haydock Mark, Spaulding Emily, Ross John F, Kiener Peter A, Almo Steven, Chaparro Rodolfo, Seidel Ronald, Suri Anish, Cemerski Saso, Pienta Kenneth J and Simcox Mary Ellen. CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20210127.